Clever Leaves Raises US$14M in Series E Financing
Summary
Clever Leaves International Inc., a multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, held the first closing of its Series E financing at US$14m. The funds may additionally support the expansion of the company’s recently launched direct-to-business sales platform, Clever Leaves 360, which offers pharmaceutical-grade cannabis extracts and finished products fit for a broad range of industries. Proceeds from the financing may also be used to further enhance operations in Colombia and to continue building out its distribution channels in Germany and throughout Europe. It is currently cultivating over 1.8 million square feet of greenhouses under Good Agricultural and Collection Practices (GACP) in Colombia. Clever Leaves is one of the world’s largest hemp and medical cannabis producers, with a global footprint encompassing brands, extraction facilities, cultivation operations and other investments across Canada, Colombia, Germany, Portugal, and the United States.